# NOVAVAX INC > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v3 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1 | | Canonical entity | alpha:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/novavax-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 26 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-09-14T14:36:15.725755+00:00 | | Last reviewed | 2026-09-14T14:36:15.725755+00:00 | ## Identity - Legal name: NOVAVAX INC - Display name: NOVAVAX INC ## Leadership - David Mott: Chairman of the Board. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2. - Alderya Therapeutics: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:3. - Amicus Therapeutics: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:3. - AuraVax Therapeutics: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:3. - Brii Biosciences: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:3. - Charles W. Newton: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:3. - Gregg H. Alton: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2. - John C. Jacobs: President and Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2. - John W. Shiver: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2. - Margaret G. McGlynn: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2. - Maryland Life Sciences Advisory: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:3. - Opus Genetics: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:3. - Rachel K. King: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2. - Richard H. Douglas: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2. - Richard J. Rodgers: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2. - Elaine O'Hara: Executive Vice President, Chief Strategy Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2. - James P. Kelly: Executive Vice President, Chief Financial Officer and Treasurer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2. - Jeffrey D. Kelly: Named Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:4. - John C. Jacobs: President and Chief Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2. - John Trizzino: Named Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:4. - Mark J. Casey: Executive Vice President, Chief Legal Officer and Corporate Secretary. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2. - Michael Casey: Executive Vice President, Chief Legal Officer and Corporate Secretary. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:4. - Ruxandra Draghia-Akli: Named Executive Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:4. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - NOVAVAX INC. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:1. ## Headquarters - US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review. ## Entity Status - Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:1. ## Published Fact - US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:1. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/novavax-inc). - alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:2: [SEC DEF 14A 0001628280-26-027328](https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm). - alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:3: [DEF 14A nvax-20260427.htm](https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm). - alpha:evidence:company:bab98dd4-6f6e-46f5-98b9-c2925f0b89c5:4: [NVAX DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1000694/000162828026027328/nvax-20260427.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. - Current index memberships: Unavailable - Index membership events: Unavailable ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/novavax-inc) - [Public Markdown](https://registry.alpha.ac/companies/novavax-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/novavax-inc) - [JSON-LD](https://registry.alpha.ac/api/public/companies/novavax-inc?format=jsonld) - MCP resource: `alpha://companies/novavax-inc` at https://mcp.alpha.ac/mcp